ÇELİK, S. Et Al. 2022. Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.38, no.2 , 282-289.

ÇELİK, S., KAYNAR, L., GÜVEN, Z. T., BAYDAR, M., KEKLİK, M., ÇETİN, M., ... ÜNAL, A.(2022). Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.38, no.2, 282-289.

ÇELİK, SERHAT Et Al. "Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy," INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.38, no.2, 282-289, 2022

ÇELİK, SERHAT Et Al. "Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy." INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.38, no.2, pp.282-289, 2022

ÇELİK, S. Et Al. (2022) . "Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy." INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.38, no.2, pp.282-289.

@article{article, author={SERHAT ÇELİK Et Al. }, title={Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy}, journal={INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION}, year=2022, pages={282-289} }